Compile Data Set for Download or QSAR
Report error Found 232 of affinity data for UniProtKB/TrEMBL: P05112
TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM50409058(CHEMBL5266734)
Affinity DataKd:  1.80E+3nMAssay Description:Inhibition of IL-4 (unknown origin) assessed as dissociation constant by SPR analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM50409058(CHEMBL5266734)
Affinity DataEC50:  3.10E+3nMAssay Description:Inhibition of IL-4 (unknown origin) in human THP-1 cells assessed as inhibition of STAT6 phosphorylation by HEK-Blue assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589948(US11559538, Example 195 | US11559538, Example 196)
Affinity DataIC50: 0.290nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589948(US11559538, Example 195 | US11559538, Example 196)
Affinity DataIC50: 0.360nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589753(US11559538, Example 16 | US11559538, Example 48 | ...)
Affinity DataIC50: 0.540nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589760(US11559538, Example 23 | US11559538, Example 124 |...)
Affinity DataIC50: 0.610nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589754(US11559538, Example 17 | US11559538, Example 50)
Affinity DataIC50: 0.650nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589930(US11559538, Example 178 | US11559538, Example 179)
Affinity DataIC50: 0.720nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589803(US11559538, Example 60 | US11559538, Example 61 | ...)
Affinity DataIC50: 0.730nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589744(US11559538, Example 8 | US11559538, Example 228)
Affinity DataIC50: 0.760nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589886(US11559538, Example 138 | US11559538, Example 139 ...)
Affinity DataIC50: 0.780nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589753(US11559538, Example 16 | US11559538, Example 48 | ...)
Affinity DataIC50: 0.820nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589848(US11559538, Example 102 | US11559538, Example 103)
Affinity DataIC50: 0.830nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589758(US11559538, Example 21 | US11559538, Example 189 |...)
Affinity DataIC50: 0.840nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589830(US11559538, Example 84 | US11559538, Example 85)
Affinity DataIC50: 0.900nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589830(US11559538, Example 84 | US11559538, Example 85)
Affinity DataIC50: 0.900nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589754(US11559538, Example 17 | US11559538, Example 50)
Affinity DataIC50: 1.04nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589958(US11559538, Example 205)
Affinity DataIC50: 1.06nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589886(US11559538, Example 138 | US11559538, Example 139 ...)
Affinity DataIC50: 1.08nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589919(US11559538, Example 167 | US11559538, Example 168)
Affinity DataIC50: 1.17nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589985(US11559538, Example 231)
Affinity DataIC50: 1.25nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589881(US11559538, Example 133)
Affinity DataIC50: 1.37nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589919(US11559538, Example 167 | US11559538, Example 168)
Affinity DataIC50: 1.37nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589751(US11559538, Example 15 | US11559538, Example 47)
Affinity DataIC50: 1.41nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589976(US11559538, Example 222 | US11559538, Example 223)
Affinity DataIC50: 1.44nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589759(US11559538, Example 22 | US11559538, Example 54)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589882(US11559538, Example 134)
Affinity DataIC50: 1.79nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589930(US11559538, Example 178 | US11559538, Example 179)
Affinity DataIC50: 1.81nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589755(US11559538, Example 18 | US11559538, Example 51)
Affinity DataIC50: 1.91nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589803(US11559538, Example 60 | US11559538, Example 61 | ...)
Affinity DataIC50: 2.04nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589848(US11559538, Example 102 | US11559538, Example 103)
Affinity DataIC50: 2.07nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589933(US11559538, Example 181)
Affinity DataIC50: 2.23nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589761(US11559538, Example 24 | US11559538, Example 56)
Affinity DataIC50: 2.24nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589748(US11559538, Example 12 | US11559538, Example 44 | ...)
Affinity DataIC50: 2.32nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589746(US11559538, Example 10 | US11559538, Example 11 | ...)
Affinity DataIC50: 2.39nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589923(US11559538, Example 171)
Affinity DataIC50: 2.43nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589756(US11559538, Example 19)
Affinity DataIC50: 2.56nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589803(US11559538, Example 60 | US11559538, Example 61 | ...)
Affinity DataIC50: 2.66nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589895(US11559538, Example 147 | US11559538, Example 148)
Affinity DataIC50: 2.69nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589802(US11559538, Example 58 | US11559538, Example 194)
Affinity DataIC50: 2.85nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589792(US11559538, Example 49 | US11559538, Example 111)
Affinity DataIC50: 3.01nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589750(US11559538, Example 14)
Affinity DataIC50: 3.21nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589972(US11559538, Example 218 | US11559538, Example 219)
Affinity DataIC50: 3.24nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589889(US11559538, Example 141 | US11559538, Example 143 ...)
Affinity DataIC50: 3.35nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589837(US11559538, Example 91 | US11559538, Example 92)
Affinity DataIC50: 3.36nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589886(US11559538, Example 138 | US11559538, Example 139 ...)
Affinity DataIC50: 3.47nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589739(US11559538, Example 3)
Affinity DataIC50: 3.54nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589745(US11559538, Example 9)
Affinity DataIC50: 3.63nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589755(US11559538, Example 18 | US11559538, Example 51)
Affinity DataIC50: 3.73nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetInterleukin-4(Human)
Roche Innovation Center Shanghai

Curated by ChEMBL
LigandPNGBDBM589772(US11559538, Example 31)
Affinity DataIC50: 3.92nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 232 total ) | Next | Last >>
Jump to: